Diffusion Pharmaceuticals (DFFN) Stockholders Approve Merger with EIP Pharma Aug 15, 2023 04:01PM
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma Aug 15, 2023 04:01PM
EIP Pharma and Diffusion Pharmaceuticals (DFFN) Announce Merger Agreement Mar 30, 2023 07:01AM
EIP Pharma and Diffusion Pharmaceuticals Announce Merger Agreement to Create Leading CNS-focused Company Treating Neurodegenerative Diseases Mar 30, 2023 07:00AM
Diffusion Pharmaceuticals Sends Letter to Stockholders Highlighting Strength of Board Leadership and Positive Progress in Strategic Review, Cautioning Stockholders Regarding LifeSci’s History of Sto Dec 5, 2022 06:30AM


Nov 14, 2022 04:01PM Diffusion Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
Nov 14, 2022 06:32AM Diffusion Pharmaceuticals (DFFN) Reports Significant Progress in its Strategic Review Process
Nov 14, 2022 06:30AM Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process
Oct 25, 2022 06:30AM Diffusion Pharmaceuticals (DFFN) Announces Strategic Review Process to Evaluate Value-Enhancing Alternatives including Opportunities to Better Leverage TSC
Oct 25, 2022 06:30AM Diffusion Pharmaceuticals Announces Strategic Review Process to Evaluate Value-Enhancing Alternatives including Opportunities to Better Leverage TSC